Novel Nucleic Acid Detection for Human Parvovirus B19 Based on Pyrococcus furiosus Argonaute Protein
Viruses · 2023
DOI: 10.3390/v15030595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Weiran Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Key Laboratory of Industrial Biotechnology, Hubei Collaborative Innovation Center …. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Pyrococcus furiosus, Parvoviridae Infections. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Biocatalysis and Enzyme Engineering, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Parvovirus B19 (B19V) is pathogenic to humans and causes various human diseases. However, no antiviral agents or vaccines currently exist for the treatment or prevention of B19V infection. Therefore, developing sensitive and specific methods for B19V infection diagnosis is essential for accurate diagnoses. Previously, a Clustered Regularly Interspaced Palindromic Repeats (CRISPR)-Cas12a (cpf1)-based electrochemical biosensor (E-CRISPR) with a picomole sensitivity for B19V detection was established. Herein, we set up a novel nucleic acid detection system based on Pyrococcus furiosus Argonaute (PfAgo)-mediated nucleic acid detection, targeting the nonstructural protein 1 (NS1) region of the B19V viral genome (abbreviated B19-NS1 PAND). Benefiting from independent protospacer adjacent motif (PAM) sequences, PfAgo can recognize their target with guide DNA (gDNA) that is easy to design and synthesize at a low cost. In contrast to E-CRISPR, without preamplification with Polymerase Chain Reaction (PCR), the Minimum Detectable Concentration (MDC) of three guide- or single guide-mediated B19-NS1 PAND was about 4 nM, approximately 6-fold more than E-CRISPR. However, when introducing an amplification step, the MDC can be dramatically decreased to the aM level (54 aM). In addition, the diagnostic results from clinical samples with B19-NS1 PAND revealed 100% consistency with PCR assays and subsequent Sanger sequencing tests, which may assist in molecular testing for clinical diagnosis and epidemiological investigations of B19V.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Key Laboratory of Industrial Biotechnology, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, School of Life Sciences, Hu…
- School of Basic Medicine, Hubei University of Arts and Sciences, Xiangyang 441053, China.
- Hubei Jiangxia Laboratory, Wuhan 430200, China.
ORCID-Profile: Lixin Ma, Yanming Dong
Förderung
- State Key Laboratory of Biocatalysis and Enzyme Engineering
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Xiangyang City Science and Technology Bureau Project
Zitieren
APA
Chen, W., Qiu, L., Luo, T., Lu, Z., Wang, X., Hong, Q., Luo, J., Ma, L., Wang, Y., & Dong, Y. (2023). Novel Nucleic Acid Detection for Human Parvovirus B19 Based on Pyrococcus furiosus Argonaute Protein. Viruses. https://doi.org/10.3390/v15030595
Vancouver
Chen W, Qiu L, Luo T, Lu Z, Wang X, Hong Q, et al. Novel Nucleic Acid Detection for Human Parvovirus B19 Based on Pyrococcus furiosus Argonaute Protein. Viruses. 2023. doi:10.3390/v15030595
BibTeX
@article{Chen2023,
author = {Chen, Weiran and Qiu, Liyang and Luo, Ting and Lu, Zhongqin and Wang, Xueying and Hong, Qi and Luo, Jingwen and Ma, Lixin and Wang, Yuan and Dong, Yanming},
title = {Novel Nucleic Acid Detection for Human Parvovirus B19 Based on Pyrococcus furiosus Argonaute Protein},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15030595}
}
EUVIMED